Olodaterol Inhaler For COPD: What To Know About Striverdi

About olodaterol

Olodaterol is a type of medicine known as a long-acting beta₂-agonist bronchodilator. It is primarily prescribed for adults with chronic obstructive pulmonary disease (COPD), a progressive lung condition encompassing chronic bronchitis and emphysema that causes persistent airflow limitation.

The medication works by stimulating beta₂-receptors in the smooth muscles of the airways, leading to relaxation and widening of the air passages. This facilitates easier breathing, reduces symptoms such as coughing, wheezing, shortness of breath, and chest tightness, and improves lung function over time. Unlike short-acting relievers, olodaterol provides sustained effects for up to 24 hours, making it suitable for once-daily maintenance therapy.

Olodaterol is marketed under the brand name Striverdi® Respimat®, delivered via the innovative Respimat soft mist inhaler. This device produces a slow-moving mist that enhances lung deposition, independent of the patient’s inspiratory flow rate, which is particularly beneficial for COPD patients with weakened breathing capacity. The FDA approved Striverdi Respimat in July 2014 based on robust Phase III trials involving over 4,450 patients, demonstrating significant improvements in lung function and symptom control.

A combination product, Spiolto® (olodaterol with tiotropium, a long-acting muscarinic antagonist), is available for patients requiring dual bronchodilation to further optimize therapy, especially in moderate to severe cases.

Key facts about olodaterol inhaler

• Used for: Long-term management of COPD in adults, including chronic bronchitis and emphysema.
• Type of medicine: Long-acting beta₂-agonist bronchodilator.
• Brand names: Striverdi® Respimat®; also in Spiolto® with tiotropium.
• Available as: Inhalation spray via Respimat cartridge device.
• Dosage: One inhalation (5 mcg olodaterol) once daily, preferably at the same time each day.
• Onset and duration: Starts working within 5 minutes, peaks at 1-3 hours, lasts 24 hours.
• Not for: Acute COPD exacerbations, asthma, or as a rescue inhaler.

COPD affects millions worldwide, characterized by irreversible airflow obstruction due to alveolar damage and airway inflammation. Olodaterol addresses this by providing consistent bronchodilation, potentially reducing exacerbation frequency when used as part of comprehensive management.

How to use olodaterol inhalers

Olodaterol is administered using the Respimat inhaler, a propellant-free device that delivers a precise dose in a soft mist. Always follow the patient instructions provided with the device. Prime the inhaler before first use or if not used for more than 3 days (actuate 3 times until a spray is visible) or 21 days (actuate 7 times).

1. Remove the clear base by pressing the safety catch and pulling off.
2. Insert the cartridge with the inhaler pointing upwards until it clicks.
3. Replace the clear base and rotate it in a clockwise direction until it locks (dose indicator shows 60).
4. Hold upright with the green cap closed; turn the base fully counterclockwise then back clockwise until it clicks.
5. Open the cap fully until it snaps; breathe out fully away from the device.
6. Seal lips around the mouthpiece, press the dose release button while inhaling steadily and deeply.
7. Hold breath for 10 seconds, then exhale slowly; close the cap.

Rinse your mouth with water after use to prevent throat irritation, but do not swallow the water. The cartridge lasts 30 days (60 actuations); discard when the dose indicator reaches 0 or 3 months after opening. Clean the mouthpiece weekly with a damp tissue; do not immerse in water.

If you miss a dose, take it as soon as remembered unless it’s near the next dose—do not double up. Forgetting doses reduces effectiveness, so integrate into daily routine.

Getting the most from your treatment

To maximize benefits, use olodaterol consistently every day, even if feeling well, as it prevents symptoms rather than treating sudden attacks. Pair with pulmonary rehabilitation, smoking cessation, vaccinations (flu/pneumococcal), and oxygen if prescribed.

Monitor symptoms: if breathlessness worsens, rescue inhaler use increases, or frequent exacerbations occur, consult your doctor promptly—do not adjust dose yourself. Diabetics should track blood glucose, as beta-agonists may elevate levels. Lifestyle measures like exercise tolerance training enhance outcomes.

Avoid beta-blockers unless cardioselective, as they antagonize effects. Store at room temperature, protected from frost and direct sunlight; keep out of children’s reach.

Common questions about olodaterol inhalers

Olodaterol is maintenance-only; sudden symptoms require a short-acting beta-agonist like albuterol. It’s not addictive but stopping abruptly may worsen symptoms—taper under medical guidance. The Respimat design improves delivery in severe COPD.

Side-effects of olodaterol inhalers

Most side effects are mild and transient. Clinical trials reported low discontinuation rates.

Report to doctor: Worsening breathing, chest pain, tremors, insomnia, urinary retention. Overdose risks tachycardia, hypokalemia—seek immediate help.

For common issues: Throat irritation—use spacer or rinse mouth; dizziness—avoid driving.

How to cope with olodaterol inhaler side effects

• Nose/throat irritation: Pharmacist-recommended lozenges or saline spray.
• Dizziness: Rest until resolved; avoid machinery.
• Rash: Antihistamines or consult doctor.
• Cough: Persistent? Check technique or inhaler cleanliness.

Side effects often improve over time. Discuss alternatives if intolerable.

Pregnancy and breastfeeding

Limited data; use only if benefits outweigh risks. Animal studies show no direct harm, but beta-agonists may delay labor. Consult specialist; consider alternatives. Unknown in breast milk—monitor infant for irritability.

Cautions of olodaterol inhalers

Contraindicated in acute deteriorations or asthma. Caution in cardiovascular disease, diabetes, hyperthyroidism, seizures, QT prolongation. Drug interactions: MAOIs, tricyclics, diuretics, other beta-agonists.

Regular monitoring advised; taper before surgery.

Other medicines, food, and olodaterol inhalers

No food interactions. Inform doctor of all meds, especially sympathomimetics, beta-blockers, QT-prolongers. May potentiate hypokalemia with steroids/diuretics.

Frequently asked questions

What if I forget a dose?

Take as soon as possible unless near next dose; skip and resume schedule—never double.

Can I use with other inhalers?

Yes, but space 5-10 minutes apart; avoid duplicate LABAs.

Does it work straight away?

Effects start in 5 minutes, full within hours; daily use for best results.

Is it safe long-term?

Yes, 48-week trials confirm safety and efficacy.

Can children use it?

No, approved for adults only.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb